nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—Atenolol—Procarbazine—hematologic cancer	0.47	1	CrCrCtD
Pindolol—CYP2D6—Lomustine—hematologic cancer	0.0354	0.189	CbGbCtD
Pindolol—CYP2D6—Idarubicin—hematologic cancer	0.0315	0.168	CbGbCtD
Pindolol—CYP2D6—Hydroxyurea—hematologic cancer	0.0268	0.143	CbGbCtD
Pindolol—CYP2D6—Bortezomib—hematologic cancer	0.0233	0.124	CbGbCtD
Pindolol—CYP2D6—Imatinib—hematologic cancer	0.0171	0.0912	CbGbCtD
Pindolol—CYP2D6—Nilotinib—hematologic cancer	0.0155	0.0829	CbGbCtD
Pindolol—CYP2D6—Vinorelbine—hematologic cancer	0.0154	0.0822	CbGbCtD
Pindolol—CYP2D6—Vinblastine—hematologic cancer	0.00949	0.0506	CbGbCtD
Pindolol—CYP2D6—Dexamethasone—hematologic cancer	0.00703	0.0375	CbGbCtD
Pindolol—CYP2D6—Doxorubicin—hematologic cancer	0.00583	0.0311	CbGbCtD
Pindolol—Isoprenaline—PIK3R1—hematologic cancer	0.00173	0.544	CrCbGaD
Pindolol—Acebutolol—SLC22A1—hematologic cancer	0.000623	0.195	CrCbGaD
Pindolol—Nadolol—ABCB1—hematologic cancer	0.000225	0.0705	CrCbGaD
Pindolol—Atenolol—ABCB1—hematologic cancer	0.000196	0.0615	CrCbGaD
Pindolol—Acebutolol—ABCB1—hematologic cancer	0.000181	0.0568	CrCbGaD
Pindolol—Metoprolol—ABCB1—hematologic cancer	0.000153	0.0479	CrCbGaD
Pindolol—Propranolol—ABCB1—hematologic cancer	7.72e-05	0.0242	CrCbGaD
Pindolol—Cardiac disorder—Methotrexate—hematologic cancer	6.77e-05	0.000245	CcSEcCtD
Pindolol—Fatigue—Triamcinolone—hematologic cancer	6.77e-05	0.000245	CcSEcCtD
Pindolol—Sweating—Doxorubicin—hematologic cancer	6.75e-05	0.000244	CcSEcCtD
Pindolol—Rash—Vincristine—hematologic cancer	6.74e-05	0.000244	CcSEcCtD
Pindolol—Dermatitis—Vincristine—hematologic cancer	6.73e-05	0.000244	CcSEcCtD
Pindolol—Pain—Triamcinolone—hematologic cancer	6.71e-05	0.000243	CcSEcCtD
Pindolol—Headache—Vincristine—hematologic cancer	6.69e-05	0.000242	CcSEcCtD
Pindolol—Loss of consciousness—Prednisone—hematologic cancer	6.68e-05	0.000242	CcSEcCtD
Pindolol—Hypotension—Dexamethasone—hematologic cancer	6.65e-05	0.000241	CcSEcCtD
Pindolol—Hypotension—Betamethasone—hematologic cancer	6.65e-05	0.000241	CcSEcCtD
Pindolol—Nausea—Carmustine—hematologic cancer	6.65e-05	0.000241	CcSEcCtD
Pindolol—Angiopathy—Methotrexate—hematologic cancer	6.62e-05	0.00024	CcSEcCtD
Pindolol—Vomiting—Irinotecan—hematologic cancer	6.61e-05	0.000239	CcSEcCtD
Pindolol—Vomiting—Mitoxantrone—hematologic cancer	6.61e-05	0.000239	CcSEcCtD
Pindolol—Nausea—Alitretinoin—hematologic cancer	6.58e-05	0.000238	CcSEcCtD
Pindolol—Visual impairment—Epirubicin—hematologic cancer	6.58e-05	0.000238	CcSEcCtD
Pindolol—Mediastinal disorder—Methotrexate—hematologic cancer	6.58e-05	0.000238	CcSEcCtD
Pindolol—Rash—Mitoxantrone—hematologic cancer	6.56e-05	0.000237	CcSEcCtD
Pindolol—Rash—Irinotecan—hematologic cancer	6.56e-05	0.000237	CcSEcCtD
Pindolol—Dermatitis—Mitoxantrone—hematologic cancer	6.55e-05	0.000237	CcSEcCtD
Pindolol—Dermatitis—Irinotecan—hematologic cancer	6.55e-05	0.000237	CcSEcCtD
Pindolol—Headache—Irinotecan—hematologic cancer	6.52e-05	0.000236	CcSEcCtD
Pindolol—Headache—Mitoxantrone—hematologic cancer	6.52e-05	0.000236	CcSEcCtD
Pindolol—Nausea—Ifosfamide—hematologic cancer	6.51e-05	0.000236	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.49e-05	0.000235	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.49e-05	0.000235	CcSEcCtD
Pindolol—Myalgia—Prednisone—hematologic cancer	6.47e-05	0.000234	CcSEcCtD
Pindolol—Arthralgia—Prednisone—hematologic cancer	6.47e-05	0.000234	CcSEcCtD
Pindolol—Feeling abnormal—Triamcinolone—hematologic cancer	6.47e-05	0.000234	CcSEcCtD
Pindolol—Diarrhoea—Cisplatin—hematologic cancer	6.46e-05	0.000234	CcSEcCtD
Pindolol—Anxiety—Prednisone—hematologic cancer	6.45e-05	0.000233	CcSEcCtD
Pindolol—Vomiting—Gemcitabine—hematologic cancer	6.44e-05	0.000233	CcSEcCtD
Pindolol—Insomnia—Betamethasone—hematologic cancer	6.44e-05	0.000233	CcSEcCtD
Pindolol—Insomnia—Dexamethasone—hematologic cancer	6.44e-05	0.000233	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—hematologic cancer	6.43e-05	0.000233	CcSEcCtD
Pindolol—Paraesthesia—Betamethasone—hematologic cancer	6.39e-05	0.000231	CcSEcCtD
Pindolol—Paraesthesia—Dexamethasone—hematologic cancer	6.39e-05	0.000231	CcSEcCtD
Pindolol—Mental disorder—Methotrexate—hematologic cancer	6.39e-05	0.000231	CcSEcCtD
Pindolol—Rash—Gemcitabine—hematologic cancer	6.39e-05	0.000231	CcSEcCtD
Pindolol—Dermatitis—Gemcitabine—hematologic cancer	6.38e-05	0.000231	CcSEcCtD
Pindolol—Tinnitus—Epirubicin—hematologic cancer	6.37e-05	0.00023	CcSEcCtD
Pindolol—Headache—Gemcitabine—hematologic cancer	6.35e-05	0.00023	CcSEcCtD
Pindolol—Nausea—Vincristine—hematologic cancer	6.35e-05	0.00023	CcSEcCtD
Pindolol—Cardiac disorder—Epirubicin—hematologic cancer	6.34e-05	0.000229	CcSEcCtD
Pindolol—Dyspepsia—Betamethasone—hematologic cancer	6.27e-05	0.000227	CcSEcCtD
Pindolol—Dyspepsia—Dexamethasone—hematologic cancer	6.27e-05	0.000227	CcSEcCtD
Pindolol—Asthenia—Etoposide—hematologic cancer	6.21e-05	0.000225	CcSEcCtD
Pindolol—Oedema—Prednisone—hematologic cancer	6.2e-05	0.000224	CcSEcCtD
Pindolol—Angiopathy—Epirubicin—hematologic cancer	6.19e-05	0.000224	CcSEcCtD
Pindolol—Nausea—Irinotecan—hematologic cancer	6.18e-05	0.000224	CcSEcCtD
Pindolol—Nausea—Mitoxantrone—hematologic cancer	6.18e-05	0.000224	CcSEcCtD
Pindolol—Mediastinal disorder—Epirubicin—hematologic cancer	6.15e-05	0.000223	CcSEcCtD
Pindolol—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.15e-05	0.000223	CcSEcCtD
Pindolol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.15e-05	0.000223	CcSEcCtD
Pindolol—Fatigue—Betamethasone—hematologic cancer	6.14e-05	0.000222	CcSEcCtD
Pindolol—Fatigue—Dexamethasone—hematologic cancer	6.14e-05	0.000222	CcSEcCtD
Pindolol—Pruritus—Etoposide—hematologic cancer	6.12e-05	0.000222	CcSEcCtD
Pindolol—Shock—Prednisone—hematologic cancer	6.1e-05	0.000221	CcSEcCtD
Pindolol—Pain—Dexamethasone—hematologic cancer	6.09e-05	0.00022	CcSEcCtD
Pindolol—Pain—Betamethasone—hematologic cancer	6.09e-05	0.00022	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—hematologic cancer	6.09e-05	0.00022	CcSEcCtD
Pindolol—Nervous system disorder—Prednisone—hematologic cancer	6.08e-05	0.00022	CcSEcCtD
Pindolol—Tachycardia—Prednisone—hematologic cancer	6.05e-05	0.000219	CcSEcCtD
Pindolol—Nausea—Gemcitabine—hematologic cancer	6.02e-05	0.000218	CcSEcCtD
Pindolol—Vomiting—Cisplatin—hematologic cancer	6.01e-05	0.000217	CcSEcCtD
Pindolol—Hyperhidrosis—Prednisone—hematologic cancer	6e-05	0.000217	CcSEcCtD
Pindolol—Mental disorder—Epirubicin—hematologic cancer	5.98e-05	0.000216	CcSEcCtD
Pindolol—Rash—Cisplatin—hematologic cancer	5.96e-05	0.000216	CcSEcCtD
Pindolol—Dermatitis—Cisplatin—hematologic cancer	5.95e-05	0.000215	CcSEcCtD
Pindolol—Diarrhoea—Etoposide—hematologic cancer	5.92e-05	0.000214	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—hematologic cancer	5.89e-05	0.000213	CcSEcCtD
Pindolol—Feeling abnormal—Betamethasone—hematologic cancer	5.87e-05	0.000212	CcSEcCtD
Pindolol—Feeling abnormal—Dexamethasone—hematologic cancer	5.87e-05	0.000212	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—hematologic cancer	5.86e-05	0.000212	CcSEcCtD
Pindolol—Flatulence—Epirubicin—hematologic cancer	5.86e-05	0.000212	CcSEcCtD
Pindolol—Tension—Epirubicin—hematologic cancer	5.83e-05	0.000211	CcSEcCtD
Pindolol—Gastrointestinal pain—Betamethasone—hematologic cancer	5.82e-05	0.000211	CcSEcCtD
Pindolol—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.82e-05	0.000211	CcSEcCtD
Pindolol—Nervousness—Epirubicin—hematologic cancer	5.77e-05	0.000209	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—hematologic cancer	5.73e-05	0.000207	CcSEcCtD
Pindolol—Dizziness—Etoposide—hematologic cancer	5.72e-05	0.000207	CcSEcCtD
Pindolol—Muscle spasms—Epirubicin—hematologic cancer	5.71e-05	0.000207	CcSEcCtD
Pindolol—Vertigo—Methotrexate—hematologic cancer	5.71e-05	0.000206	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—hematologic cancer	5.69e-05	0.000206	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.65e-05	0.000204	CcSEcCtD
Pindolol—Dizziness—Prednisolone—hematologic cancer	5.64e-05	0.000204	CcSEcCtD
Pindolol—Asthenia—Triamcinolone—hematologic cancer	5.63e-05	0.000204	CcSEcCtD
Pindolol—Abdominal pain—Betamethasone—hematologic cancer	5.63e-05	0.000204	CcSEcCtD
Pindolol—Abdominal pain—Dexamethasone—hematologic cancer	5.63e-05	0.000204	CcSEcCtD
Pindolol—Nausea—Cisplatin—hematologic cancer	5.61e-05	0.000203	CcSEcCtD
Pindolol—Insomnia—Prednisone—hematologic cancer	5.61e-05	0.000203	CcSEcCtD
Pindolol—Paraesthesia—Prednisone—hematologic cancer	5.57e-05	0.000202	CcSEcCtD
Pindolol—Pruritus—Triamcinolone—hematologic cancer	5.55e-05	0.000201	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—hematologic cancer	5.53e-05	0.0002	CcSEcCtD
Pindolol—Vomiting—Etoposide—hematologic cancer	5.5e-05	0.000199	CcSEcCtD
Pindolol—Dyspepsia—Prednisone—hematologic cancer	5.46e-05	0.000198	CcSEcCtD
Pindolol—Rash—Etoposide—hematologic cancer	5.46e-05	0.000197	CcSEcCtD
Pindolol—Dermatitis—Etoposide—hematologic cancer	5.45e-05	0.000197	CcSEcCtD
Pindolol—Headache—Etoposide—hematologic cancer	5.42e-05	0.000196	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—hematologic cancer	5.42e-05	0.000196	CcSEcCtD
Pindolol—Chest pain—Methotrexate—hematologic cancer	5.41e-05	0.000196	CcSEcCtD
Pindolol—Arthralgia—Methotrexate—hematologic cancer	5.41e-05	0.000196	CcSEcCtD
Pindolol—Myalgia—Methotrexate—hematologic cancer	5.41e-05	0.000196	CcSEcCtD
Pindolol—Tension—Doxorubicin—hematologic cancer	5.4e-05	0.000195	CcSEcCtD
Pindolol—Rash—Prednisolone—hematologic cancer	5.38e-05	0.000195	CcSEcCtD
Pindolol—Dermatitis—Prednisolone—hematologic cancer	5.38e-05	0.000195	CcSEcCtD
Pindolol—Fatigue—Prednisone—hematologic cancer	5.35e-05	0.000194	CcSEcCtD
Pindolol—Headache—Prednisolone—hematologic cancer	5.35e-05	0.000194	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—hematologic cancer	5.34e-05	0.000193	CcSEcCtD
Pindolol—Vertigo—Epirubicin—hematologic cancer	5.34e-05	0.000193	CcSEcCtD
Pindolol—Syncope—Epirubicin—hematologic cancer	5.33e-05	0.000193	CcSEcCtD
Pindolol—Constipation—Prednisone—hematologic cancer	5.3e-05	0.000192	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—hematologic cancer	5.29e-05	0.000191	CcSEcCtD
Pindolol—Palpitations—Epirubicin—hematologic cancer	5.25e-05	0.00019	CcSEcCtD
Pindolol—Confusional state—Methotrexate—hematologic cancer	5.23e-05	0.000189	CcSEcCtD
Pindolol—Loss of consciousness—Epirubicin—hematologic cancer	5.22e-05	0.000189	CcSEcCtD
Pindolol—Dizziness—Triamcinolone—hematologic cancer	5.19e-05	0.000188	CcSEcCtD
Pindolol—Nausea—Etoposide—hematologic cancer	5.14e-05	0.000186	CcSEcCtD
Pindolol—Feeling abnormal—Prednisone—hematologic cancer	5.11e-05	0.000185	CcSEcCtD
Pindolol—Asthenia—Dexamethasone—hematologic cancer	5.11e-05	0.000185	CcSEcCtD
Pindolol—Asthenia—Betamethasone—hematologic cancer	5.11e-05	0.000185	CcSEcCtD
Pindolol—Nervous system disorder—Methotrexate—hematologic cancer	5.08e-05	0.000184	CcSEcCtD
Pindolol—Gastrointestinal pain—Prednisone—hematologic cancer	5.07e-05	0.000184	CcSEcCtD
Pindolol—Nausea—Prednisolone—hematologic cancer	5.07e-05	0.000183	CcSEcCtD
Pindolol—Arthralgia—Epirubicin—hematologic cancer	5.06e-05	0.000183	CcSEcCtD
Pindolol—Chest pain—Epirubicin—hematologic cancer	5.06e-05	0.000183	CcSEcCtD
Pindolol—Myalgia—Epirubicin—hematologic cancer	5.06e-05	0.000183	CcSEcCtD
Pindolol—Anxiety—Epirubicin—hematologic cancer	5.04e-05	0.000182	CcSEcCtD
Pindolol—Pruritus—Betamethasone—hematologic cancer	5.04e-05	0.000182	CcSEcCtD
Pindolol—Pruritus—Dexamethasone—hematologic cancer	5.04e-05	0.000182	CcSEcCtD
Pindolol—Hyperhidrosis—Methotrexate—hematologic cancer	5.01e-05	0.000181	CcSEcCtD
Pindolol—Vomiting—Triamcinolone—hematologic cancer	4.99e-05	0.000181	CcSEcCtD
Pindolol—Rash—Triamcinolone—hematologic cancer	4.95e-05	0.000179	CcSEcCtD
Pindolol—Dry mouth—Epirubicin—hematologic cancer	4.95e-05	0.000179	CcSEcCtD
Pindolol—Dermatitis—Triamcinolone—hematologic cancer	4.94e-05	0.000179	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—hematologic cancer	4.94e-05	0.000179	CcSEcCtD
Pindolol—Syncope—Doxorubicin—hematologic cancer	4.93e-05	0.000178	CcSEcCtD
Pindolol—Headache—Triamcinolone—hematologic cancer	4.92e-05	0.000178	CcSEcCtD
Pindolol—Abdominal pain—Prednisone—hematologic cancer	4.9e-05	0.000177	CcSEcCtD
Pindolol—Confusional state—Epirubicin—hematologic cancer	4.89e-05	0.000177	CcSEcCtD
Pindolol—Diarrhoea—Dexamethasone—hematologic cancer	4.87e-05	0.000176	CcSEcCtD
Pindolol—Diarrhoea—Betamethasone—hematologic cancer	4.87e-05	0.000176	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—hematologic cancer	4.86e-05	0.000176	CcSEcCtD
Pindolol—Oedema—Epirubicin—hematologic cancer	4.85e-05	0.000176	CcSEcCtD
Pindolol—Hypotension—Methotrexate—hematologic cancer	4.84e-05	0.000175	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—hematologic cancer	4.83e-05	0.000175	CcSEcCtD
Pindolol—Shock—Epirubicin—hematologic cancer	4.77e-05	0.000173	CcSEcCtD
Pindolol—Nervous system disorder—Epirubicin—hematologic cancer	4.76e-05	0.000172	CcSEcCtD
Pindolol—Tachycardia—Epirubicin—hematologic cancer	4.73e-05	0.000171	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.72e-05	0.000171	CcSEcCtD
Pindolol—Dizziness—Dexamethasone—hematologic cancer	4.71e-05	0.00017	CcSEcCtD
Pindolol—Dizziness—Betamethasone—hematologic cancer	4.71e-05	0.00017	CcSEcCtD
Pindolol—Hyperhidrosis—Epirubicin—hematologic cancer	4.69e-05	0.00017	CcSEcCtD
Pindolol—Insomnia—Methotrexate—hematologic cancer	4.69e-05	0.00017	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—hematologic cancer	4.68e-05	0.000169	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—hematologic cancer	4.68e-05	0.000169	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—hematologic cancer	4.68e-05	0.000169	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—hematologic cancer	4.67e-05	0.000169	CcSEcCtD
Pindolol—Nausea—Triamcinolone—hematologic cancer	4.66e-05	0.000169	CcSEcCtD
Pindolol—Paraesthesia—Methotrexate—hematologic cancer	4.65e-05	0.000168	CcSEcCtD
Pindolol—Dyspnoea—Methotrexate—hematologic cancer	4.62e-05	0.000167	CcSEcCtD
Pindolol—Somnolence—Methotrexate—hematologic cancer	4.61e-05	0.000167	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—hematologic cancer	4.58e-05	0.000166	CcSEcCtD
Pindolol—Dyspepsia—Methotrexate—hematologic cancer	4.56e-05	0.000165	CcSEcCtD
Pindolol—Hypotension—Epirubicin—hematologic cancer	4.53e-05	0.000164	CcSEcCtD
Pindolol—Vomiting—Betamethasone—hematologic cancer	4.53e-05	0.000164	CcSEcCtD
Pindolol—Vomiting—Dexamethasone—hematologic cancer	4.53e-05	0.000164	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—hematologic cancer	4.53e-05	0.000164	CcSEcCtD
Pindolol—Rash—Betamethasone—hematologic cancer	4.49e-05	0.000163	CcSEcCtD
Pindolol—Rash—Dexamethasone—hematologic cancer	4.49e-05	0.000163	CcSEcCtD
Pindolol—Oedema—Doxorubicin—hematologic cancer	4.49e-05	0.000162	CcSEcCtD
Pindolol—Dermatitis—Betamethasone—hematologic cancer	4.49e-05	0.000162	CcSEcCtD
Pindolol—Dermatitis—Dexamethasone—hematologic cancer	4.49e-05	0.000162	CcSEcCtD
Pindolol—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.47e-05	0.000162	CcSEcCtD
Pindolol—Fatigue—Methotrexate—hematologic cancer	4.47e-05	0.000162	CcSEcCtD
Pindolol—Headache—Betamethasone—hematologic cancer	4.46e-05	0.000161	CcSEcCtD
Pindolol—Headache—Dexamethasone—hematologic cancer	4.46e-05	0.000161	CcSEcCtD
Pindolol—Asthenia—Prednisone—hematologic cancer	4.45e-05	0.000161	CcSEcCtD
Pindolol—Pain—Methotrexate—hematologic cancer	4.43e-05	0.00016	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.42e-05	0.00016	CcSEcCtD
Pindolol—Shock—Doxorubicin—hematologic cancer	4.42e-05	0.00016	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—hematologic cancer	4.4e-05	0.000159	CcSEcCtD
Pindolol—Pruritus—Prednisone—hematologic cancer	4.39e-05	0.000159	CcSEcCtD
Pindolol—Insomnia—Epirubicin—hematologic cancer	4.39e-05	0.000159	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—hematologic cancer	4.38e-05	0.000159	CcSEcCtD
Pindolol—Paraesthesia—Epirubicin—hematologic cancer	4.36e-05	0.000158	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—hematologic cancer	4.34e-05	0.000157	CcSEcCtD
Pindolol—Dyspnoea—Epirubicin—hematologic cancer	4.32e-05	0.000157	CcSEcCtD
Pindolol—Somnolence—Epirubicin—hematologic cancer	4.31e-05	0.000156	CcSEcCtD
Pindolol—Feeling abnormal—Methotrexate—hematologic cancer	4.27e-05	0.000155	CcSEcCtD
Pindolol—Dyspepsia—Epirubicin—hematologic cancer	4.27e-05	0.000155	CcSEcCtD
Pindolol—Diarrhoea—Prednisone—hematologic cancer	4.24e-05	0.000154	CcSEcCtD
Pindolol—Gastrointestinal pain—Methotrexate—hematologic cancer	4.24e-05	0.000153	CcSEcCtD
Pindolol—Nausea—Dexamethasone—hematologic cancer	4.23e-05	0.000153	CcSEcCtD
Pindolol—Nausea—Betamethasone—hematologic cancer	4.23e-05	0.000153	CcSEcCtD
Pindolol—Hypotension—Doxorubicin—hematologic cancer	4.19e-05	0.000152	CcSEcCtD
Pindolol—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.19e-05	0.000152	CcSEcCtD
Pindolol—Fatigue—Epirubicin—hematologic cancer	4.18e-05	0.000151	CcSEcCtD
Pindolol—Pain—Epirubicin—hematologic cancer	4.15e-05	0.00015	CcSEcCtD
Pindolol—Constipation—Epirubicin—hematologic cancer	4.15e-05	0.00015	CcSEcCtD
Pindolol—Dizziness—Prednisone—hematologic cancer	4.1e-05	0.000148	CcSEcCtD
Pindolol—Abdominal pain—Methotrexate—hematologic cancer	4.1e-05	0.000148	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.09e-05	0.000148	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—hematologic cancer	4.06e-05	0.000147	CcSEcCtD
Pindolol—Paraesthesia—Doxorubicin—hematologic cancer	4.03e-05	0.000146	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—hematologic cancer	4e-05	0.000145	CcSEcCtD
Pindolol—Feeling abnormal—Epirubicin—hematologic cancer	4e-05	0.000145	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—hematologic cancer	3.99e-05	0.000144	CcSEcCtD
Pindolol—Gastrointestinal pain—Epirubicin—hematologic cancer	3.97e-05	0.000144	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—hematologic cancer	3.95e-05	0.000143	CcSEcCtD
Pindolol—Vomiting—Prednisone—hematologic cancer	3.94e-05	0.000143	CcSEcCtD
Pindolol—Rash—Prednisone—hematologic cancer	3.91e-05	0.000142	CcSEcCtD
Pindolol—Dermatitis—Prednisone—hematologic cancer	3.91e-05	0.000141	CcSEcCtD
Pindolol—Headache—Prednisone—hematologic cancer	3.89e-05	0.000141	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.87e-05	0.00014	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—hematologic cancer	3.87e-05	0.00014	CcSEcCtD
Pindolol—Pain—Doxorubicin—hematologic cancer	3.84e-05	0.000139	CcSEcCtD
Pindolol—Constipation—Doxorubicin—hematologic cancer	3.84e-05	0.000139	CcSEcCtD
Pindolol—Abdominal pain—Epirubicin—hematologic cancer	3.83e-05	0.000139	CcSEcCtD
Pindolol—Asthenia—Methotrexate—hematologic cancer	3.72e-05	0.000135	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—hematologic cancer	3.7e-05	0.000134	CcSEcCtD
Pindolol—Nausea—Prednisone—hematologic cancer	3.68e-05	0.000133	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.67e-05	0.000133	CcSEcCtD
Pindolol—Pruritus—Methotrexate—hematologic cancer	3.67e-05	0.000133	CcSEcCtD
Pindolol—Abdominal pain—Doxorubicin—hematologic cancer	3.55e-05	0.000128	CcSEcCtD
Pindolol—Diarrhoea—Methotrexate—hematologic cancer	3.55e-05	0.000128	CcSEcCtD
Pindolol—Asthenia—Epirubicin—hematologic cancer	3.48e-05	0.000126	CcSEcCtD
Pindolol—Pruritus—Epirubicin—hematologic cancer	3.43e-05	0.000124	CcSEcCtD
Pindolol—Dizziness—Methotrexate—hematologic cancer	3.43e-05	0.000124	CcSEcCtD
Pindolol—Diarrhoea—Epirubicin—hematologic cancer	3.32e-05	0.00012	CcSEcCtD
Pindolol—Vomiting—Methotrexate—hematologic cancer	3.3e-05	0.000119	CcSEcCtD
Pindolol—Rash—Methotrexate—hematologic cancer	3.27e-05	0.000118	CcSEcCtD
Pindolol—Dermatitis—Methotrexate—hematologic cancer	3.27e-05	0.000118	CcSEcCtD
Pindolol—Headache—Methotrexate—hematologic cancer	3.25e-05	0.000118	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—hematologic cancer	3.22e-05	0.000117	CcSEcCtD
Pindolol—Dizziness—Epirubicin—hematologic cancer	3.21e-05	0.000116	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—hematologic cancer	3.18e-05	0.000115	CcSEcCtD
Pindolol—Vomiting—Epirubicin—hematologic cancer	3.08e-05	0.000112	CcSEcCtD
Pindolol—Nausea—Methotrexate—hematologic cancer	3.08e-05	0.000111	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—hematologic cancer	3.07e-05	0.000111	CcSEcCtD
Pindolol—Rash—Epirubicin—hematologic cancer	3.06e-05	0.000111	CcSEcCtD
Pindolol—Dermatitis—Epirubicin—hematologic cancer	3.06e-05	0.000111	CcSEcCtD
Pindolol—Headache—Epirubicin—hematologic cancer	3.04e-05	0.00011	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—hematologic cancer	2.97e-05	0.000107	CcSEcCtD
Pindolol—Nausea—Epirubicin—hematologic cancer	2.88e-05	0.000104	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—hematologic cancer	2.85e-05	0.000103	CcSEcCtD
Pindolol—Rash—Doxorubicin—hematologic cancer	2.83e-05	0.000102	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—hematologic cancer	2.83e-05	0.000102	CcSEcCtD
Pindolol—Headache—Doxorubicin—hematologic cancer	2.81e-05	0.000102	CcSEcCtD
Pindolol—Nausea—Doxorubicin—hematologic cancer	2.67e-05	9.65e-05	CcSEcCtD
Pindolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	7.93e-06	0.000125	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCND1—hematologic cancer	7.91e-06	0.000125	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—JUN—hematologic cancer	7.9e-06	0.000125	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL2RA—hematologic cancer	7.86e-06	0.000124	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL2—hematologic cancer	7.8e-06	0.000123	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TERT—hematologic cancer	7.77e-06	0.000123	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	7.76e-06	0.000123	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	7.75e-06	0.000123	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CDKN1A—hematologic cancer	7.65e-06	0.000121	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PTEN—hematologic cancer	7.64e-06	0.000121	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAP2K1—hematologic cancer	7.61e-06	0.00012	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PDGFB—hematologic cancer	7.59e-06	0.00012	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	7.58e-06	0.00012	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CD—hematologic cancer	7.56e-06	0.000119	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—PIK3CA—hematologic cancer	7.49e-06	0.000118	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MAPK8—hematologic cancer	7.47e-06	0.000118	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	7.46e-06	0.000118	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AKT1—hematologic cancer	7.45e-06	0.000118	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TSC2—hematologic cancer	7.41e-06	0.000117	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—KRAS—hematologic cancer	7.4e-06	0.000117	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	7.38e-06	0.000117	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	7.29e-06	0.000115	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EP300—hematologic cancer	7.28e-06	0.000115	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	7.24e-06	0.000115	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—FGF2—hematologic cancer	7.24e-06	0.000114	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	7.22e-06	0.000114	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	7.15e-06	0.000113	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3R1—hematologic cancer	7.14e-06	0.000113	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FGFR3—hematologic cancer	7.13e-06	0.000113	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	7.08e-06	0.000112	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SRC—hematologic cancer	7.08e-06	0.000112	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	7.07e-06	0.000112	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	7.07e-06	0.000112	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK14—hematologic cancer	7.06e-06	0.000112	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NQO1—hematologic cancer	7.05e-06	0.000111	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CD44—hematologic cancer	7.05e-06	0.000111	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	7e-06	0.000111	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	7e-06	0.000111	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—JAK2—hematologic cancer	6.94e-06	0.00011	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ESR1—hematologic cancer	6.93e-06	0.00011	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	6.92e-06	0.000109	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	6.92e-06	0.000109	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—hematologic cancer	6.9e-06	0.000109	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	6.86e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	6.85e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	6.85e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	6.85e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	6.85e-06	0.000108	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FN1—hematologic cancer	6.84e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—STAT3—hematologic cancer	6.83e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NRAS—hematologic cancer	6.81e-06	0.000108	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PIK3CA—hematologic cancer	6.8e-06	0.000107	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MDM2—hematologic cancer	6.77e-06	0.000107	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NFKBIA—hematologic cancer	6.76e-06	0.000107	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—BAD—hematologic cancer	6.76e-06	0.000107	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	6.73e-06	0.000106	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	6.71e-06	0.000106	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	6.7e-06	0.000106	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	6.7e-06	0.000106	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	6.7e-06	0.000106	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOTCH1—hematologic cancer	6.7e-06	0.000106	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYCS—hematologic cancer	6.67e-06	0.000105	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	6.63e-06	0.000105	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MTOR—hematologic cancer	6.59e-06	0.000104	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CB—hematologic cancer	6.59e-06	0.000104	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	6.58e-06	0.000104	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CD80—hematologic cancer	6.56e-06	0.000104	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	6.56e-06	0.000104	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CG—hematologic cancer	6.55e-06	0.000104	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KIT—hematologic cancer	6.55e-06	0.000104	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—NRAS—hematologic cancer	6.55e-06	0.000104	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MAPK3—hematologic cancer	6.53e-06	0.000103	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	6.52e-06	0.000103	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	6.44e-06	0.000102	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PTPN11—hematologic cancer	6.43e-06	0.000102	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	6.41e-06	0.000101	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	6.38e-06	0.000101	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	6.37e-06	0.000101	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	6.36e-06	0.000101	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	6.35e-06	0.0001	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MYC—hematologic cancer	6.35e-06	0.0001	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TGFB1—hematologic cancer	6.33e-06	0.0001	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	6.3e-06	9.95e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HRAS—hematologic cancer	6.29e-06	9.94e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—MAPK3—hematologic cancer	6.27e-06	9.91e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	6.24e-06	9.86e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CREB1—hematologic cancer	6.23e-06	9.85e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	6.22e-06	9.83e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	6.21e-06	9.82e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1B—hematologic cancer	6.18e-06	9.77e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—BRAF—hematologic cancer	6.16e-06	9.73e-05	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT1—hematologic cancer	6.11e-06	9.67e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCL2—hematologic cancer	6.1e-06	9.64e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6R—hematologic cancer	6.08e-06	9.61e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CREBBP—hematologic cancer	6.07e-06	9.6e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CASP3—hematologic cancer	6.06e-06	9.58e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	6.06e-06	9.58e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL2—hematologic cancer	6.05e-06	9.56e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—IL6—hematologic cancer	6.02e-06	9.52e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	6.02e-06	9.52e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.96e-06	9.42e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	5.93e-06	9.37e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCND1—hematologic cancer	5.9e-06	9.32e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	5.89e-06	9.32e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	5.89e-06	9.31e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—JUN—hematologic cancer	5.88e-06	9.3e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.88e-06	9.29e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KRAS—hematologic cancer	5.86e-06	9.27e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	5.83e-06	9.22e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	5.8e-06	9.16e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	5.76e-06	9.11e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	5.76e-06	9.11e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	5.76e-06	9.1e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1A—hematologic cancer	5.7e-06	9.02e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	5.7e-06	9.01e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PTEN—hematologic cancer	5.69e-06	9e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	5.68e-06	8.98e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	5.64e-06	8.91e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	5.64e-06	8.91e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK8—hematologic cancer	5.57e-06	8.8e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ABCB1—hematologic cancer	5.56e-06	8.8e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	5.56e-06	8.79e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT1—hematologic cancer	5.55e-06	8.78e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	5.52e-06	8.73e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FGF2—hematologic cancer	5.51e-06	8.71e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	5.44e-06	8.59e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EP300—hematologic cancer	5.43e-06	8.58e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	5.41e-06	8.56e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	5.4e-06	8.54e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NCOR1—hematologic cancer	5.4e-06	8.54e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTM1—hematologic cancer	5.4e-06	8.54e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	5.39e-06	8.52e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CA—hematologic cancer	5.39e-06	8.52e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	5.3e-06	8.37e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—JAK2—hematologic cancer	5.28e-06	8.35e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SRC—hematologic cancer	5.28e-06	8.35e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	5.27e-06	8.34e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	5.25e-06	8.29e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	5.25e-06	8.29e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TP53—hematologic cancer	5.21e-06	8.24e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	5.18e-06	8.19e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MDM2—hematologic cancer	5.16e-06	8.15e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—hematologic cancer	5.14e-06	8.13e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	5.13e-06	8.11e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	5.13e-06	8.11e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—STAT3—hematologic cancer	5.09e-06	8.05e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NRAS—hematologic cancer	5.08e-06	8.03e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	5.02e-06	7.93e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MTOR—hematologic cancer	5.02e-06	7.93e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	5.01e-06	7.92e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HRAS—hematologic cancer	4.98e-06	7.88e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	4.92e-06	7.78e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	4.9e-06	7.75e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	4.87e-06	7.7e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK3—hematologic cancer	4.86e-06	7.69e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	4.83e-06	7.63e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	4.82e-06	7.62e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	4.82e-06	7.61e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	4.79e-06	7.58e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	4.79e-06	7.57e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.77e-06	7.55e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6—hematologic cancer	4.77e-06	7.54e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	4.76e-06	7.53e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MYC—hematologic cancer	4.73e-06	7.48e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	4.72e-06	7.46e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TGFB1—hematologic cancer	4.72e-06	7.46e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	4.71e-06	7.45e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	4.71e-06	7.44e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	4.7e-06	7.43e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	4.69e-06	7.41e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	4.69e-06	7.41e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	4.66e-06	7.36e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CASP3—hematologic cancer	4.62e-06	7.3e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL2—hematologic cancer	4.61e-06	7.29e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	4.59e-06	7.26e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6—hematologic cancer	4.59e-06	7.25e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	4.58e-06	7.25e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	4.54e-06	7.18e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	4.53e-06	7.17e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCND1—hematologic cancer	4.49e-06	7.1e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—JUN—hematologic cancer	4.48e-06	7.09e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	4.44e-06	7.03e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	4.43e-06	7.01e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	4.43e-06	7.01e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	4.42e-06	6.99e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT1—hematologic cancer	4.4e-06	6.96e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KRAS—hematologic cancer	4.37e-06	6.91e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	4.35e-06	6.87e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	4.34e-06	6.86e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PTEN—hematologic cancer	4.34e-06	6.85e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	4.33e-06	6.84e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	4.32e-06	6.83e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	4.24e-06	6.71e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	4.23e-06	6.69e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	4.23e-06	6.69e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	4.2e-06	6.65e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EP300—hematologic cancer	4.14e-06	6.54e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	4.11e-06	6.5e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	4.09e-06	6.47e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	4.05e-06	6.41e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	4.04e-06	6.39e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SRC—hematologic cancer	4.02e-06	6.36e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CA—hematologic cancer	4.02e-06	6.35e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.01e-06	6.34e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	4.01e-06	6.33e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	3.97e-06	6.27e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	3.96e-06	6.25e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	3.92e-06	6.19e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TP53—hematologic cancer	3.88e-06	6.14e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—STAT3—hematologic cancer	3.88e-06	6.13e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	3.87e-06	6.12e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NRAS—hematologic cancer	3.87e-06	6.12e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	3.79e-06	5.99e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	3.77e-06	5.96e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	3.76e-06	5.94e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.72e-06	5.88e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HRAS—hematologic cancer	3.72e-06	5.87e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	3.7e-06	5.86e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	3.69e-06	5.83e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	3.68e-06	5.81e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MYC—hematologic cancer	3.6e-06	5.7e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	3.59e-06	5.68e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6—hematologic cancer	3.56e-06	5.62e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.53e-06	5.57e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	3.48e-06	5.5e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALB—hematologic cancer	3.48e-06	5.5e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	3.41e-06	5.38e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.33e-06	5.26e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KRAS—hematologic cancer	3.33e-06	5.26e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT1—hematologic cancer	3.28e-06	5.19e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	3.2e-06	5.06e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	3.13e-06	4.95e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	3.09e-06	4.89e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.07e-06	4.86e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	3.06e-06	4.84e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	3.03e-06	4.78e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TP53—hematologic cancer	2.96e-06	4.68e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	2.96e-06	4.68e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	2.89e-06	4.58e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	2.83e-06	4.48e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HRAS—hematologic cancer	2.83e-06	4.47e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	2.77e-06	4.38e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6—hematologic cancer	2.71e-06	4.28e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTEN—hematologic cancer	2.66e-06	4.2e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	2.61e-06	4.13e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	2.56e-06	4.04e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—EP300—hematologic cancer	2.53e-06	4e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT1—hematologic cancer	2.5e-06	3.95e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.87e-06	2.96e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKT1—hematologic cancer	1.53e-06	2.42e-05	CbGpPWpGaD
